Acidic nanoparticles for restoration of autophagy
US-2024252675-A1 · Aug 1, 2024 · US
US9504761B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9504761-B2 |
| Application number | US-201113090732-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 20, 2011 |
| Priority date | Apr 20, 2011 |
| Publication date | Nov 29, 2016 |
| Grant date | Nov 29, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A stabilized chitosan-based nanoparticle is provided having a chitosan polymer and a hydrophilic dispersing agent. In the stabilized nanoparticle, chains of the chitosan polymer electrostatically interact with chains of the hydrophilic dispersing agent to form an entangled network between the chitosan polymer and the hydrophilic dispersing agent. The stabilized chitosan-based nanoparticle has optimal particle integrity and stability properties under physiological conditions.
Opening claim text (preview).
The invention claimed is: 1. A stabilized chitosan-based nanoparticle comprising: a chitosan polymer and a polyglutamic acid; wherein chains of the chitosan polymer electrostatically interact with chains of the the polyglutamic acid to form an entangled network comprising the chitosan polymer and the polyglutamic acid; and wherein the polyglutamic acid and the chitosan polymer are at a molar ratio of from 1:5 to 1:20 polyglutamic acid to chitosan polymer and the polyglutamic acid is of a molecular weight such that the nanoparticle has a particle size of between about 20 nm and about 100 nm and has a zeta potential of at least +32 mV. 2. The stabilized chitosan-based nanoparticle of claim 1 , wherein the nanoparticle comprises a transmittance value of at least 99% at 500 nm and at a pH of about 7.4 or less. 3. The stabilized chitosan-based nanoparticle of claim 1 , further comprising an imaging agent linked to the nanoparticle, wherein the imaging agent comprises at least one of a fluorophore and a paramagnetic chelate having a paramagnetic ion bound therein such that the nanoparticle is effective as an MRI contrast medium. 4. The stabilized chitosan-based nanoparticle of claim 1 , further comprising a target-specific ligand linked to the nanoparticle, wherein the target-specific ligand has a binding affinity for a predetermined molecular target. 5. The stabilized chitosan-based nanoparticle of claim 4 , wherein the ligand is selected from the group consisting of an aptamer, a peptide, an oligonucleotide, folate, an antigen, an antibody, and combinations thereof. 6. The stabilized chitosan-based nanoparticle of claim 1 , wherein the nanoparticle is free from a cross-linking compound that covalently links the chains of the chitosan polymer to the chains of the hydrophilic dispersing agent. 7. The stabilized chitosan-based nanoparticle of claim 1 made by the process comprising reacting components of a first microemulsion and a second microemulsion for a time sufficient to form a stabilized chitosan-based nanoparticle comprising a chitosan polymer and a hydrophilic dispersing agent, wherein the first microemulsion comprises an oil, a surfactant, and an aqueous phase comprising a chitosan polymer and the second microemulsion comprises an oil, a surfactant, and an aqueous phase comprising a hydrophilic dispersing agent; and recovering the stabilized chitosan-based nanoparticle from the reacted first and second microemulsion components. 8. The stabilized chitosan-based nanoparticle of claim 7 , wherein a molar ratio of the hydrophilic dispersing agent to the chitosan polymer is about 1:10. 9. The stabilized chitosan-based nanoparticle of claim 1 , wherein the molar ratio is about 1:10.
by coagulating dispersions {(C08J3/122 takes precedence)} · CPC title
one of the codrug's components being a vitamin, e.g. niacinamide, vitamin B3, cobalamin, vitamin B12, folate, vitamin A or retinoic acid · CPC title
characterised by structure or composition · CPC title
Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof · CPC title
the polymer being obtained otherwise than by reactions involving carbon to carbon unsaturated bonds, e.g. polyesters, polyamides or polyglycerol · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.